Uropathogenic Escherichia coli
Background|Fimbriae and Motility StudiesSecreted Autotransporter Studies (Sat, Pic, and Tsh)
Genomic Studies on Uropathogenic E. coliReferences
1. Kahlmeter, G., An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother, 2003. 51(1): p. 69-76.
2. Ronald, A., The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon, 2003. 49(2): p. 71-82.
3. Warren, J.W., Urinary Tract Infections: Molecular Pathogenesis and Clinical Management. 1 ed, ed. J.W. Warren. 1996, Washington, D.C.: ASM Press. 439.
4. Finer, G. and D. Landau, Pathogenesis of urinary tract infections with normal female anatomy. Lancet Infect Dis, 2004. 4(10): p. 631-5.
5. Johnson, J.R. and T.A. Russo, Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli. Int J Med Microbiol, 2005. 295(6-7): p. 383-404.
6. Johnson, J.R., Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev, 1991. 4(1): p. 80-128.
7. Manges, A.R., J.R. Johnson, B. Foxman, T.T. O'Bryan, K.E. Fullerton, and L.W. Riley, Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med, 2001. 345(14): p. 1007-13.
8. Gupta, K., T.M. Hooton, and W.E. Stamm, Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med, 2001. 135(1): p. 41-50.
9. Langermann, S., R. Mollby, J.E. Burlein, et al., Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J Infect Dis, 2000. 181(2): p. 774-8.
10. Langermann, S. and W.R. Ballou, Jr., Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections. J Infect Dis, 2001. 183 Suppl 1: p. S84-6.
11. Uehling, D.T., L.J. James, W.J. Hopkins, and E. Balish, Immunization against urinary tract infection with a multi-valent vaginal vaccine. J Urol, 1991. 146(1): p. 223-6.
12. Uehling, D.T., W.J. Hopkins, L.A. Dahmer, and E. Balish, Phase I clinical trial of vaginal mucosal immunization for recurrent urinary tract infection. J Urol, 1994. 152(6 Pt 2): p. 2308-11.
13. Uehling, D.T., W.J. Hopkins, L.J. James, and E. Balish, Vaginal immunization of monkeys against urinary tract infection with a multi-strain vaccine. J Urol, 1994. 151(1): p. 214-6.
14. Uehling, D.T., W.J. Hopkins, E. Balish, Y. Xing, and D.M. Heisey, Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial. J Urol, 1997. 157(6): p. 2049-52.
15. Uehling, D.T., W.J. Hopkins, J.E. Elkahwaji, D.M. Schmidt, and G.E. Leverson, Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections. J Urol, 2003. 170(3): p. 867-9.
16. Mobley, H.L., D.M. Green, A.L. Trifillis, D.E. Johnson, G.R. Chippendale, C.V. Lockatell, B.D. Jones, and J.W. Warren, Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun, 1990. 58(5): p. 1281-9.
17. Welch, R.A., V. Burland, G. Plunkett, 3rd, et al., Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A, 2002. 99(26): p. 17020-4.
18. Snyder, J.A., B.J. Haugen, E.L. Buckles, C.V. Lockatell, D.E. Johnson, M.S. Donnenberg, R.A. Welch, and H.L. Mobley, Transcriptome of Uropathogenic Escherichia coli during Urinary Tract Infection. Infect Immun, 2004. 72: p. 6373-6381.
19. Molloy, M.P., B.R. Herbert, M.B. Slade, T. Rabilloud, A.S. Nouwens, K.L. Williams, and A.A. Gooley, Proteomic analysis of the Escherichia coli outer membrane. Eur J Biochem, 2000. 267(10): p. 2871-81.
20. Unlu, M., M.E. Morgan, and J.S. Minden, Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis, 1997. 18(11): p. 2071-7.
21. Tielker, D., S. Hacker, R. Loris, M. Strathmann, J. Wingender, S. Wilhelm, F. Rosenau, and K.E. Jaeger, Pseudomonas aeruginosa lectin LecB is located in the outer membrane and is involved in biofilm formation. Microbiology, 2005. 151(Pt 5): p. 1313-23.
22. Wilhelm, S., J. Tommassen, and K.E. Jaeger, A novel lipolytic enzyme located in the outer membrane of Pseudomonas aeruginosa. J Bacteriol, 1999. 181(22): p. 6977-86.